Just The News

FoodTech: How Engineered Food and Gastronomical Gadgets Affect Your Health

2 days ago

Here on Medgadget, we cover a lot of groundbreaking devices that save lives and improve health. But one often overlooked topic deals with something each and every one of us use every day: food. Food is essential for our survival, and one can say it interacts with our bodies more intimately than any medical product, so […]

FDA releases framework guidelines for regenerative med development

2 days ago

The FDA this week laid out guidelines for a new framework it’s implementing for the development and oversight of regenerative medicine products including novel cellular therapies. The framework is laid out through four guidance documents which build on the FDA’s existing regulatory approach and describe more clearly which products are regulated as drugs, devices and […]

The post FDA releases framework guidelines for regenerative med development appeared first on MassDevice.

Amgen launches Enbrel Mini single-dose cartridges with reusable auto-injector

2 days ago

Amgen (NSDQ:AMGN) announced today the U.S. launch of its Enbrel Mini single-dose prefilled cartridges, which are delivered using a reusable AutoTouch auto-injector. The drug-device combination was designed with a needle that stays hidden during injection and a sensor to detect placement on the skin. Get the full story at our sister site, Drug Delivery Business News.

The post Amgen launches Enbrel Mini single-dose cartridges with reusable auto-injector appeared first on MassDevice.

Belluscura plans IPO to commercialize licensed Stryker IP

2 days ago

Medical device group Belluscura is planning a U.K.-based IPO that could be worth up to $13.2 million after it picked up the rights to make and sell certain Stryker (NYSE:SYK) devices, according to a filing from the company. The company was created by Tekcapital in 2015 to pick up and commercialize rights to medical devices. So […]

The post Belluscura plans IPO to commercialize licensed Stryker IP appeared first on MassDevice.

Here’s what the FDA is doing about IV fluid shortages following hurricanes Maria, Irma

2 days ago

Nine weeks after hurricanes Maria and Irma brought devastation to Puerto Rico, FDA commissioner Dr. Scott Gottlieb says hospitals across the U.S. are reporting shortages of IV fluids – medical products that are often sourced from Puerto Rico. Hospitals are specifically noting that 0.9% injection bags of saline, used to inject drugs intravenously, are of […]

The post Here’s what the FDA is doing about IV fluid shortages following hurricanes Maria, Irma appeared first on MassDevice.

House Committee urges HHS to improve med device cybersecurity

2 days ago

The US House Energy and Commerce committee is looking to the Department of Health and Human Services to shore up medical device cybersecurity, according to a report from The Hill. Committee Chair Greg Walden (R-Ore.) sent a letter to the HHS asking it to require device makers to provide a listed bill of materials, including […]

The post House Committee urges HHS to improve med device cybersecurity appeared first on MassDevice.

Align Technology expands iTero distro, integration deal with Glidewell

2 days ago

Align Technology (NSDQ:ALGN) said today it expanded a distribution deal with Glidewell Dental to distribute Align’s iTero Element intraoral scanning system in North America. Through the deal, San Jose, Calif.-based Align’s said its iTero Element scanner will feature Glidewell’s fastdesign.io software which serves to auto-design restorations for clinician approval and to communicate with a lab’s digital […]

The post Align Technology expands iTero distro, integration deal with Glidewell appeared first on MassDevice.

JDRF touts win after Anthem decides to cover artificial pancreas systems

2 days ago

JDRF said today it successfully persuaded Anthem to cover artificial pancreas systems, after meeting the health insurer as part of is Coverage2Control campaign. America’s 25 largest health insurers now cover Medtronic‘s (NYSE:MDT) MiniMed system, according to the organization. Get the full story at our sister site, Drug Delivery Business News.

The post JDRF touts win after Anthem decides to cover artificial pancreas systems appeared first on MassDevice.

7 medtech stories we missed this week: Nov. 17, 2017

2 days ago

From Skyline Medical’s joint venture to Lensar receiving FDA clearance and CE Mark, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. Skyline Medical launches JV deal with Helomics Skyline Medical announced in a Nov. 15 press release that it has signed a joint venture agreement with Helomics. […]

The post 7 medtech stories we missed this week: Nov. 17, 2017 appeared first on MassDevice.

EasyScan GO: AI Powered Malaria Parasite Counter

2 days ago

EasyScan GO, an AI powered microscope developed by Chinese manufacturer Motic, has the capability to automatically and accurately quantify malaria parasites in a blood sample. Utilizing machine learning algorithms, the microscope is so efficient that it can identify the amount of parasites present in under 20 minutes. Premiered at the International Conference on Computer Vision […]

Staar Surgical plans pivotal of Visian EVO ICL presbyopia optic for Q1 2018

2 days ago

Staar Surgical (NSDQ:STAA) this week reported results from the feasibility clinical study of its Evo+ Visian ICL with aspheric optics designed to reduce presbyopia, and that based on the results it plans to launch a pivotal clinical study of the device during the 1st quarter next year. The Monrovia, Calif.-based company’s EVO+ Visian ICL is designed […]

The post Staar Surgical plans pivotal of Visian EVO ICL presbyopia optic for Q1 2018 appeared first on MassDevice.

Neovasc raises $65m to cover damages in CardiAQ case

2 days ago

Neovasc (NSDQ:NVCN) said today it closed an offering of approximately $37.5 million and a private placement of approximately $27.8 million to cover the roughly $42 million balance of damages and interest in a litigation with Edwards Lifesciences (NYSE:EW) subsidiary CardiAQ Valve. In its offering, Neovasc offered approximately 6.6 million Series A units and 19.1 million Series B units at a […]

The post Neovasc raises $65m to cover damages in CardiAQ case appeared first on MassDevice.

EYEMATE Implantable Continuous Intraocular Pressure Monitor Validated in Initial Patients

2 days ago

Implandata, a Hannover, Germany firm, just announced that the first patients has been implanted with its EYEMATE continuous intraocular pressure (IOP) monitor and the technology passed initial validation. Glaucoma, as well as a few other less common eye conditions, require regular IOP measurements in order to properly adjust how much medications to take. Typically, this […]

Implandata Ophthalmic touts 1st-in-human use of next-gen Eyemate IOP sensor

2 days ago

Implandata Ophthalmic Products today touted the first-in-human use of its next-gen Eyemate micro-sensor implant designed to monitor intraocular pressure. The Eyemate microsensor is designed for the continuous monitoring of intraocular pressure and can be checked remotely, removing the need for a patient to visit a doctor’s office for measurements, the Hannover, Germany-based company said. “This […]

The post Implandata Ophthalmic touts 1st-in-human use of next-gen Eyemate IOP sensor appeared first on MassDevice.

J&J’s DePuy Ortho faces $247m ruling in Pinnacle bellwether trial

2 days ago

A Dallas federal jury this week ruled that Johnson & Johnson (NYSE:JNJ) and its DePuy Orthopaedics must pay $247 million to six patients claiming to be injured by its Pinnacle metal-on-metal hip implants, according to a Reuters report. The jury ruled that the controversial metal-on-metal hip implants were defectively designed and that patients did not receive […]

The post J&J’s DePuy Ortho faces $247m ruling in Pinnacle bellwether trial appeared first on MassDevice.

iVeena finishes pilot trial of sustained-release implant

2 days ago

iVeena Delivery Systems said earlier this month that it finished a pilot trial for its IVMED-10 bioerodible implant designed to treat pain and inflammation after cataract surgery. Placed during cataract surgery, the sustained-release implant delivers dexamethasone for two weeks from the lens capsule. Get the full story at our sister site, Drug Delivery Business News.

The post iVeena finishes pilot trial of sustained-release implant appeared first on MassDevice.

J&J notches latest win in long-running talc saga as caseload grows to 5,500

2 days ago

As the number of pending talc cases continues to tick upward, Johnson & Johnson is maintaining its defensive winning streak. On Thursday, jurors in Los Angeles sided with the company against a plaintiff who argued her mesothelioma was the result of talc use and that the product contains cancer-causing asbestos.

Researchers reverse diabetes in mice by infusing them with blood stem cells

2 days ago

Researchers at Boston Children’s Hospital successfully reversed Type I diabetes in a mouse model using blood stem cells, according to a study published this week in Science Translational Medicine. The researchers used cells that were pre-treated to make more of a protein, PD-L1, which is deficient in mice and people with Type I diabetes. “There’s really a reshaping […]

The post Researchers reverse diabetes in mice by infusing them with blood stem cells appeared first on MassDevice.

Neuropixel Probe Monitors Brain Activity Across Multiple Brain Regions

3 days ago

An international team of researchers has developed a silicon brain probe that can gather neuronal activity at an unprecedented resolution. The device, called Neuropixel, described in the latest version of Nature, is a thin needle with an unbelievable 960 electrodes that record brain signals. The resolution is at a single neuron level. Because at 10 […]

G Medical Innovaions raises $10m to support Prizma medical smartphone case

3 days ago

Mobile health dev G Medical Innovations said today it raised $10.3 million (AUSD $13.5 million) to support commercialization of its Prizma medical smartphone accessory and case. The Australian company said the round was “substantially oversubscribed,” with funds raised through the sale of 31.4 million shares at 33¢ (AUSD 43¢) per share. G Medical’s Prizma medical […]

The post G Medical Innovaions raises $10m to support Prizma medical smartphone case appeared first on MassDevice.

Titan Medical touts 1st Sport use in feasibility, validation study

3 days ago

Titan Medical (TSX:TMD) today touted the 1st use of its Sport robotic surgical platform in a preclinical feasibility and validation trial at Columbia University Medical Center’s surgical simulation center in New York. The Toronto-based company said the device had completed “critical surgical tasks integral to successful performance in gynecologic procedures” using the prototype Sport system. The demonstration […]

The post Titan Medical touts 1st Sport use in feasibility, validation study appeared first on MassDevice.

Editing genes with a more precise alternative to CRISPR

3 days ago

The gene editing technology CRISPR-Cas9 corrects genetic abnormalities by breaking two DNA strands and then inserting healthy genes or eliminating unhealthy ones. A Yale team has developed an alternative gene-editing technology that they say replaces CRISPR’s “hacksaw” effect with a more precise “scalpel.”

Editing genes with a more precise alternative to CRISPR

3 days ago

The gene editing technology CRISPR-Cas9 corrects genetic abnormalities by breaking two DNA strands and then inserting healthy genes or eliminating unhealthy ones. A Yale team has developed an alternative gene-editing technology that they say replaces CRISPR’s “hacksaw” effect with a more precise “scalpel.”

Researchers aim to create touch-sensitive, nerve-connected robotic prosthetic hand

3 days ago

Researchers at two academic facilities are aiming to create a first-of-its-kind bioengineered robotic hand that can grow and adapt to its environment, equipped with a living pathway to translate the robots touch sensation to the user’s brain. Teams from both Florida Atlantic University and the University of Utah School of Medicine said they have received […]

The post Researchers aim to create touch-sensitive, nerve-connected robotic prosthetic hand appeared first on MassDevice.

Usono ProbeFix Introduces Continuous, Hands-Free Ultrasound to The World

3 days ago

Usono, a company based in The Netherlands, has created a new kind of ultrasound accessory that is an important diagnostic tool as well as a way to improve reproducibility of ultrasound images. ProbeFix is a fixation system for transthoracic ultrasound probes that allows doctors to effortlessly image patients’ hearts without having to strain to hold […]

Shares in Delcath fall after losses grow in Q3

3 days ago

Shares in Delcath Systems (NSDQ:DCTHD) crashed today after the company posted its third quarter results, revealing that the company’s net losses have grown dramatically quarter-over-quarter. The N.Y.-based company posted a net loss of -$12.6 million on sales of $684,000 for the 3 months ended Sept. 30, for sales growth of 57% compared with the same period last year. […]

The post Shares in Delcath fall after losses grow in Q3 appeared first on MassDevice.

Virtual Reality System for Navigating Huge Brain Datasets

3 days ago

Researchers at the Wyss Center for Bio and Neuroengineering and the University of Geneva have developed a virtual reality system for navigating through and manipulating huge volumes of brain-related data. Information obtained from brain studies can balloon into gigantic quantities that is difficult to visualize and analyze. The person piloting the system wears a now […]

Alcyone Lifesciences wins FDA nod for Alivio hydrocephalus shunt flusher

3 days ago

Alcyone Lifesciences said yesterday it won FDA 510(k) clearance for its Alivio ventricular catheter and flusher system designed for treating hydrocephalus. The newly cleared Alivio device is designed for the non-invasive retrograde flushing of the ventricular catheter to unblock occluded inlet holes or open a relief membrane to restore or increase cerebrospinal fluid flow in […]

The post Alcyone Lifesciences wins FDA nod for Alivio hydrocephalus shunt flusher appeared first on MassDevice.

Insulia wins FDA nod, CE Mark clearance to titrate Tresiba, Basaglar insulin

3 days ago

Voluntis said today that its digital management system for people with Type II diabetes, Insulia, won FDA clearance and CE Mark approval to integrate basal insulin brands Tresiba and Basaglar. The company’s software already works with Lantus, Toujeo and Levemir. The Insulia digital companion is composed of a patient mobile app and healthcare worker web portal. […]

The post Insulia wins FDA nod, CE Mark clearance to titrate Tresiba, Basaglar insulin appeared first on MassDevice.

Teleflex announces upcoming $500m senior note offering

3 days ago

Teleflex (NYSE:TFX) today announced a new public offering of senior notes due 2027, looking to raise approximately $500 million. The Wayne, Penn.-based company has not yet released prices of the notes, and said that the interest rates and other terms will be determined at pricing. Teleflex said that net proceeds from the round will be used […]

The post Teleflex announces upcoming $500m senior note offering appeared first on MassDevice.

Varian Medical wins Japanese nod for Halcyon oncology radiotherapy system

3 days ago

Varian Medical (NYSE:VAR) said today it won Shonin approval from the Japanese Ministry of Health, Labor and Welfare for its Halcyon image-guided volumetric intensity modulated radiotherapy cancer treatment system. The Palo Alto, Calif.-based company said its Halcyon IMRT system features improvements that make it more comfortable for patients and streamline operator’s workflow, only requiring 9 steps […]

The post Varian Medical wins Japanese nod for Halcyon oncology radiotherapy system appeared first on MassDevice.

High-Strength Artificial Cartilage Made from Kevlar

3 days ago

Researchers at the University of Michigan and Jiangnan University in China have developed a type of artificial cartilage using Kevlar, a synthetic fiber better-known for its use in bullet-proof vests, and polyvinyl alcohol (PVA), a material used in hydrogel cartilage replacements. The new hybrid material combines the strength and water content of natural cartilage, and […]

House approves FDA fast track for battlefield treatments

3 days ago

The U.S. House of Representatives yesterday approved a measure that would create a fast track at the FDA for medical devices and drugs intended for treating battlefield injuries, a day after passing a nearly $700 billion defense policy bill that would have allowed Defense Dept. to approve the treatments without the FDA’s participation. That provision […]

The post House approves FDA fast track for battlefield treatments appeared first on MassDevice.

GE, Golden Meditech ink cord blood storage deal

3 days ago

GE Healthcare (NYSE:GE) and Golden Meditech said this week they inked a strategic collaboration deal to provide GE’s integrated and automated digital systems and solutions to Golden Meditech for use in its umbilical cord blood cryopreservation processes. Hong Kong-based Golden Meditech said that umbilical cord blood contains rich hematopoietic stem cells which could facilitate reconstruction of […]

The post GE, Golden Meditech ink cord blood storage deal appeared first on MassDevice.

Astellas joins crowd of pharmas under investigation for copay charity donations

3 days ago

Astellas has joined the biopharma who's who of companies to disclose federal scrutiny for donations to charities that help patients cover drug costs. In a legal filing, the drugmaker disclosed a federal subpoena for information about its contributions, as part of a joint criminal and civil investigation of the company, its officers and employees.

TSO3 responds to FDA info request for Sterizone VP4 duoedenoscope indications

3 days ago

TSO3 (TSE:TOS) said today it responded to a request for additional information from the FDA on its Sterizone VP4 sterilizer as it seeks an indication for the terminal sterilization of duodenoscopes. The company’s Sterizone VP4 is a low-temperature sterilization system which uses dual-sterilants of vaporized hydrogen peroxide and ozone for the terminal sterilization of heat and […]

The post TSO3 responds to FDA info request for Sterizone VP4 duoedenoscope indications appeared first on MassDevice.

Alnylam starts rolling FDA filing for patisiran

3 days ago

Alnylam has kicked off a rolling FDA filing for its RNAi drug patisiran. The gene silencing pioneer expects to complete the submission by the end of the year, setting it up to win approval in the U.S. in 2018.

Alnylam starts rolling FDA filing for patisiran

3 days ago

Alnylam has kicked off a rolling FDA filing for its RNAi drug patisiran. The gene silencing pioneer expects to complete the submission by the end of the year, setting it up to win approval in the U.S. in 2018.

X4, nearing late-phase trials of ex-Sanofi drug, raises $27M

3 days ago

X4 Pharmaceuticals has raised $27 million to advance a CXCR4 inhibitor it picked up from Sanofi. The series B equips X4 to move deeper into the clinic on two fronts, with phase 2 and 3 trials in cancers and rare diseases on the horizon.

X4, nearing late-phase trials of ex-Sanofi drug, raises $27M

3 days ago

X4 Pharmaceuticals has raised $27 million to advance a CXCR4 inhibitor it picked up from Sanofi. The series B equips X4 to move deeper into the clinic on two fronts, with phase 2 and 3 trials in cancers and rare diseases on the horizon.

In conversation with: Alice Zhang, CEO of Verge Genomics

3 days ago

Alice Zhang co-founded Verge Genomics to create a scalable drug discovery engine that automates the discovery of cures across therapeutic areas. Currently focused on neurodegenerative diseases, instead of targeting only one gene at a time, Verge uses machine learning to map out the hundreds of genes that cause a disease.

In conversation with: Alice Zhang, CEO of Verge Genomics

3 days ago

Alice Zhang co-founded Verge Genomics to create a scalable drug discovery engine that automates the discovery of cures across therapeutic areas. Currently focused on neurodegenerative diseases, instead of targeting only one gene at a time, Verge uses machine learning to map out the hundreds of genes that cause a disease.

First Electronic Device for Opioid Withdrawal Therapy Approved by FDA

4 days ago

The FDA has given a regulatory green light to the first device that reduces opioid withdrawal symptoms. The NSS-2 Bridge from Innovative Health Solutions, a Versailles, Indiana firm, is stuck to the skin behind the ear and relies on four electrodes that are attached around the ear. The electrodes are used to deliver electric current […]

Harnessing immunotherapy to reverse Type 1 diabetes

4 days ago

In patients with Type 1 diabetes, T cells in the immune system attack islet cells in the pancreas that make insulin. Scientists at Boston Children’s Hospital have come up with a way to thwart this wayward autoimmune reaction using a protein that plays a prominent role in cancer immunotherapies: PD-L1.

Harnessing immunotherapy to reverse Type 1 diabetes

4 days ago

In patients with Type 1 diabetes, T cells in the immune system attack islet cells in the pancreas that make insulin. Scientists at Boston Children’s Hospital have come up with a way to thwart this wayward autoimmune reaction using a protein that plays a prominent role in cancer immunotherapies: PD-L1.

High Speed Video Precisely Captures Blood Cell Velocity

4 days ago

Researchers at ITMO University in Saint Petersburg, Russia, have developed a non-invasive high-speed video capillaroscopy system that can precisely measure the velocity of blood cells flowing through capillaries in the skin around a fingernail. The technique could be useful in assessing cardiovascular conditions. Capillaroscopy systems offer a simple and non-invasive way to assess the size […]

Quick and Easy Deuteration and Tritiation of Potential Compounds to Speed Drug Development

4 days ago

During the development of many drugs, radioactive markers and so-called stable labels, typically deuterium and tritium respectively, are often used to trace the destination of  chemical compounds and their metabolites. This is a pretty easy thing to do in lab animals, once you have enough molecules of the compound you’re testing in which typical hydrogen […]

SleepScore Labs Releases Its Contact-Free Sleep Monitoring System

4 days ago

SleepScore Labs, a joint venture between ResMed, a medical firm focused on sleep devices, Pegasus Capital Advisors, and Dr. Mehmet Oz, is releasing the SleepScore Max sleep monitoring system. The contact-free device simply rests on the nightstand, watching the patient, and recording sleep events and what stages the person is in at different times of the […]

AstraZeneca goes to battle with GSK with nod for Nucala challenger Fasenra

4 days ago

AstraZeneca is about to find out whether its third-to-market respiratory biologic can stand out from the crowd—and a lower price might just do it. Fasenra, known in the clinic as benralizumab, won FDA approval for a severe type of asthma, and AZ is undercutting its two chief rivals.

Germano lands spot on The Medicines Company’s board

4 days ago

The Medicines Company has tweaked its board, bringing former Pfizer executive Geno Germano in as an independent director and expanding Fred Eshelman’s role. Germano takes up the position 8 months after a shift in focus at Intrexon led him to give up the president post at the synthetic biology company.

Germano lands spot on The Medicines Company’s board

4 days ago

The Medicines Company has tweaked its board, bringing former Pfizer executive Geno Germano in as an independent director and expanding Fred Eshelman’s role. Germano takes up the position 8 months after a shift in focus at Intrexon led him to give up the president post at the synthetic biology company.

Turnstone Biologics nabs Bristol-Myers R&D exec as new research chief

4 days ago

Fierce 15 winner Turnstone Biologics has poached Mike Burgess, MBChB, Ph.D., from Bristol-Myers Squibb to be its new head of R&D. Burgess, who had been at BMS as its SVP, head of exploratory clinical and translational research since 2013, has jumped ship to the early-stage startup, which is focused on reviving the fortunes of research into oncolytic viruses and cancer vaccines.

Turnstone Biologics nabs Bristol-Myers R&D exec as new research chief

4 days ago

Fierce 15 winner Turnstone Biologics has poached Mike Burgess, MBChB, Ph.D., from Bristol-Myers Squibb to be its new head of R&D. Burgess, who had been at BMS as its SVP, head of exploratory clinical and translational research since 2013, has jumped ship to the early-stage startup, which is focused on reviving the fortunes of research into oncolytic viruses and cancer vaccines.

Genentech doubles down on Arvinas, swelling deal to $650M

4 days ago

Genentech has doubled the size of its alliance with Arvinas, moving the potential value of the pact up above $650 million. The expansion of the deal gives the Roche subsidiary the chance to use Arvinas’ protein degradation technology against additional disease targets.

Genentech doubles down on Arvinas, swelling deal to $650M

4 days ago

Genentech has doubled the size of its alliance with Arvinas, moving the potential value of the pact up above $650 million. The expansion of the deal gives the Roche subsidiary the chance to use Arvinas’ protein degradation technology against additional disease targets.

Novartis chases new canakinumab niche after overall data failed to excite

5 days ago

Back in August, Novartis published findings from the phase 3 Cantos trial of Ilaris that weren't "fully compelling to payers," the company's CEO-to-be, Vas Narasimhan, said on a Monday conference call. Now, Novartis is back with subgroup data for the proposed cardiovascular drug it thinks are more promising.

Bayer pays $400M upfront to buy into Loxo cancer drugs

5 days ago

Bayer has paid $400 million (€340 million) and committed to more than $1 billion more to buy into Loxo Oncology’s tropomyosin receptor kinase inhibitor franchise. The agreement puts Bayer in charge of global commercialization of a drug that chalked up a 75% response rate in a midphase trial.

Bayer pays $400M upfront to buy into Loxo cancer drugs

5 days ago

Bayer has paid $400 million (€340 million) and committed to more than $1 billion more to buy into Loxo Oncology’s tropomyosin receptor kinase inhibitor franchise. The agreement puts Bayer in charge of global commercialization of a drug that chalked up a 75% response rate in a midphase trial.

Denali, Odonate seek $273M Nasdaq IPOs

5 days ago

Heavily backed neurodegenerative diseases biotech Denali Therapeutics and oral chemotherapy biotech Odonate Therapeutics are looking to make hay while the sun shines by filing for two big IPOs.

Denali, Odonate seek $273M Nasdaq IPOs

5 days ago

Heavily backed neurodegenerative diseases biotech Denali Therapeutics and oral chemotherapy biotech Odonate Therapeutics are looking to make hay while the sun shines by filing for two big IPOs.

MIT scientists propose a safer way to edit genes with CRISPR

6 days ago

CRISPR-Cas9 has generated excitement for its potential use in eliminating disease-causing irregularities in DNA, but most systems rely on viral vectors. Scientists at MIT have developed nanoparticles that could eliminate the need to use viruses to edit genes.

MIT scientists propose a safer way to edit genes with CRISPR

6 days ago

CRISPR-Cas9 has generated excitement for its potential use in eliminating disease-causing irregularities in DNA, but most systems rely on viral vectors. Scientists at MIT have developed nanoparticles that could eliminate the need to use viruses to edit genes.

CRISPR, Bayer JV tap CureVac for Cas9 mRNA constructs

6 days ago

CRISPR Therapeutics and its joint venture with Bayer have struck a deal with CureVac. The pact tasks CureVac with developing Cas9 mRNA constructs for use by CRISPR and joint venture Casebia Therapeutics in three in vivo gene-editing liver disease programs.

CRISPR, Bayer JV tap CureVac for Cas9 mRNA constructs

6 days ago

CRISPR Therapeutics and its joint venture with Bayer have struck a deal with CureVac. The pact tasks CureVac with developing Cas9 mRNA constructs for use by CRISPR and joint venture Casebia Therapeutics in three in vivo gene-editing liver disease programs.

Medtronic and Mazor Robotics Need Each Other

3 weeks ago

Let's just get this out of the way: Mazor wants to grow and Medtronic needs to infuse growth into their Spine business. In other words, an acquisition does not need to happen in order for this relationship to work.

What's Next for TransEnterix after Senhance's FDA Clearance

1 month ago

In typical FDA fashion, TransEnterix received their FDA clearance letter late Friday afternoon for their Senhance surgical robot which was very welcomed by investors as the stock jumped 63% in after-hours trading. Senhance is the first new entrant into

Business Travel Tip: Watch your home TV with a streaming stick

1 month ago

Your family thinks those weekly business trips are filled with dinner at the best restaurants and stays at 5-star hotels, but we, the road warriors, know it's quite the opposite. For most of us, the most expensive meal we get is from an Outback

TransEnterix is one step closer to FDA approval for Senhance

2 months ago

With the recent stock run-up, and the year coming to a close, any TRXC investor with a pulse has seen this coming for a while now. This morning, TransEnterix announced they've submitted their AI response to the FDA, setting the stage for a

NEA Backed NeoTract Acquired by Teleflex

2 months ago

Serial entrepreneur and NEA General Partner, Josh Makower, hit another home run today when Teleflex acquired NeoTract, the company he co-founded with Ted Lamson.

MedReps 2017 Medical Sales Salary Report

5 months ago

MedReps recently released their seventh annual medical sales salary report and the information for prospective medical sales representatives continues to be invaluable.

Stryker Sues Biomet for Stealing Reps and Corporate Secrets

8 months ago

Stryker (Howmedica Osteonics Corp) takes their non-compete agreements seriously, and on Wednesday, they sued three Biomet affiliates in Texas, claiming they poached Stryker employees involved in the Foot and Ankle business.

Are you a new manager? Start with this simple book

9 months ago

So you finally got your first management job! Congrats! Don't get too used to those words, though. You won't hear them too often from this point on. Wait, you got into management for the fame and recognition? Whoops...wrong career decision if that's what

Arguments begin in appeal of ex-Stryker rep’s $750k loss

10 months ago

The oral arguments began today for the appeal of a $750,000 loss an ex-Stryker rep incurred in a lawsuit over his move to Stryker's competitor, Biomet. As previously reported, Stryker sued ex-sales reps, Chris Ridgeway and Richard Steitzer, in September

MedReps' 2017 Best Places to Work in Medical Sales

10 months ago

MedReps surveyed over 1,200 community members in order to come up with the winners and some of the biggest and well know medical sales companies came out on top. The overall winners went to: Medtronic, Johnson & Johnson and Stryker.

Three tips to whip your sales territory into shape in the new year

10 months ago

The new year always comes with lofty goals, which typically start with unused gym memberships and unproductive quarterly planning meetings. They should be useful, but many times we end up going through the motions and write out unachievable goals that

Boost sales with a simple 7 step pre-call plan

11 months ago

Pre-call plans are one of the most effective tools a sales rep can use in preparing for a sales call. However, in our experience, sales reps bypass using them unless they happen to be on a field ride with their manager.

What is medtechy and how can it benefit medical sales reps?

1 year ago

Isn't Medtechy just Cafepharma for the medical device industry? The answer is no, but we've heard that question before. We understand the similarities as both sites have anonymous messages boards for pharmaceutical and medical device companies. However, a

The Medtech[y] Minute

1 year ago

It's been a busy week on the boards and our new blog, The Ticker, so we thought it would be helpful to round up the most popular topics and articles from the week and make it easy on you.

4 Tips for Managing a New Medical Sales Territory

1 year ago

A number of sales reps think sales success happens because you can schmooze and are a likable person. There is no doubt those factors can lead to one-off successes, but long-term success in sales in due to strategy and planning.

Muddy Waters Research still coming for St. Jude Medical

1 year ago

Short seller, Muddy Waters Research, and St. Jude Medical are back at it this week in what's becoming a modern day corporate pissing match. Despite being sued by St. Jude for making "false statements, false advertising, conspiracy and manipulation of

Merck Oncology Overview

1 year ago

Earlier this week, Merck provided an update to investors on their strategy in Oncology and a review of the data presented at ESMO. The global launch strategy of KEYTRUDA across several tumor types is reviewed as well.

Mazor Robotics Reports Record System Purchase Orders

1 year ago

Mazor Robotics made a splash today when they announced the company received purchase orders for 25 systems during the third quarter, including pre-orders for the Mazor X, which is scheduled to launch later this month at the North American Spine Society

Stryker still going after ex-rep, despite bankruptcy

1 year ago

Ex-Stryker rep, Chris Ridgeway, has been in the middle of a legal battle with Stryker since September 2013 when they fired and sued him, claiming he conspired with Biomet to steal Stryker's trade secrets, pricing, and obtain a distributorship deal through

The 10 Most Expensive Prescriptions of 2016

1 year ago

Healthcare startup, GoodRx, recently published their list of the most expensive prescriptions in the U.S. The data is gathered by using actual prices from a sample claims reported by pharmacies throughout the United States.

Boston Scientific CEO on Mad Money with Jim Cramer

1 year ago

Boston Scientific CEO, Mike Mahoney, sat down with Mad Money's Jim Cramer on Wednesday evening to discuss a number of topics, including how innovation has helped Boston Scientific's stock lift over 30% in the last year.

Castlight Health Investor Presentation

1 year ago

Castlight Health presented at the Morgan Stanley Global Healthcare Conference on September 12, 2016 and we will share that presentation if it becomes available. Until then, you can listen to the audio version here: Listen to webcast.

Sun Pharma sales reps to go on strike

1 year ago

According to a report in the Business Standard, around 500 sales reps are planning a strike on September 26th after Sun Pharma allegedly failed to pay salaries and travel expenses over the last three months.

Acelity Launches PREVENA PLUS™ Incision Management System

1 year ago

San Antonio based Acelity announced the launch of their PREVENA PLUS Incision Management System, offering clinicians and hospitals versatility in applying negative pressure incision management on linear, non-linear and intersecting incisions up to 90cm in

TransEnterix, Inc. Unveils New Brand Identity for ALF-X

1 year ago

North Carolina based, TransEnterix, announced the launch of their new brand name for the ALF-X Robotic Surgical System. The surgical robotic company has changed the name of ALF-X to The Senhance Surgical Robotic System.

5 Great Books For Sales Managers

1 year ago

As sales managers, continuously adapting and testing new ideas while sticking to a process are some of the main challenges in leading a team of people with a variety of skill sets. There is no one stop shop in management skills and we've found the best

Top 5 Medtech[y] Stories From the Week: August 28 2016

1 year ago

We have assembled our most read articles from the week. Check back throughout the week to read interesting stories from the Medical Device and Pharmaceutical industries as well as stories on how to become more effective in the medical sales field.

Medtronic Q1 2017 Earnings Presentation

1 year ago

In the current quarter Medtronic revenues were off 1.5%, earnings up 13% and the reiterate FY17 guidance. We will update this post with a breakdown of Medtronic's earnings by business unit.

Touch Surgery and Ethicon Team Up for Surgeon Training App

1 year ago

Johnson & Johnson subsidiary, Ethicon, announced a strategic collaboration with Touch Surgery to help improve patient outcomes by delivering simulated surgical training of Ethicon products in a free mobile app for medical professionals.

Pfizer Presentation on Medivation Acquisition

1 year ago

In an effort to keep employees and investors informed of the most up-to-date information shared by Pharmaceutical, Biotech and Medical Device Companies, we will start publishing corporate and investor presentations on The Ticker.

Medtronic Adds Another $20 investment in Mazor Robotics

1 year ago

Mazor Robotics (Nasdaq: MZOR) continues making strides as they announced Medtronic completed the second tranche investment of $20 million. As previously reported, Medtronic entered into multiple commercial and equity agreements

Apple working on a new health-related wearable device

1 year ago

The U.S. Patent & Trademark Office released a patent shows Apple wants to dig deeper into the wearable market with a device that can measure electrocardiographic signals and other heart related measurements.

Pfizer Q2 Earnings Presentation

1 year ago

In an effort to keep employees and investors informed of the most up-to-date information shared by Pharmaceutical, Biotech and Medical Device Companies, we will start publishing corporate and investor presentations on The Ticker.

Updated Intersect ENT Corporate Presentation - August 2016

1 year ago

In an effort to keep employees and investors informed of the most up-to-date information shared by Pharmaceutical, Biotech and Medical Device Companies, we will start publishing corporate and investor presentations on The Ticker.

Entellus Medical Investor Presentation August 2016

1 year ago

In an effort to keep employees and investors informed of the most up-to-date information shared by Pharmaceutical, Biotech and Medical Device Companies, we will start publishing corporate and investor presentations on The Ticker.

Must Have Products For Traveling Sales Reps

1 year ago

The life of a traveling sales rep is never as glamorous as many of our friends and family make it out to be. Instead of flying first class to New York for dinner, and then to London for meetings, most of us are slugging it away in a small commuter jet

Loading...

Email Newsletter Subscription.

Don’t you think it’s about time your (day) job got a bit easier? Us too.

Register today and we’ll add you to our mailing list.

I am a